Published in Br Med J on August 19, 1967
Small-bowel abnormalities in dermatitis herpetiformis. Br Med J (1968) 2.02
Small-intestinal mucosal abnormalities in various skin diseases--fact or fancy? Gut (1970) 1.46
Incidence of small-intestinal mucosal abnormalities and of clinical coeliac disease in the relatives of children with coeliac disease. Gut (1971) 1.28
Dermatogenic enteropathy. Gut (1970) 1.04
Intestinal malabsorption and the skin. Gut (1971) 0.90
The gut and the skin. Postgrad Med J (1970) 0.83
Mucosal architecture of the small bowel in cases of psoriasis. Gut (1971) 0.81
Cytokinetic studies of crypts in convoluted human small-intestinal mucosa. J Clin Pathol (1979) 0.80
Electron microscope findings in the jejunal mucosa of patients with psoriasis. Arch Klin Exp Dermatol (1970) 0.80
The fatty-acid spectrum in plasma and adipose tissue in patients with psoriasis. Arch Dermatol Res (1985) 0.75
Skin disease and the gut. Br Med J (1970) 0.75
[Size and function of the spleen in psoriasis]. Arch Dermatol Forsch (1972) 0.75
Intraluminal biopsy of the small intestine; the intestinal biopsy capsule. Am J Dig Dis (1957) 13.22
Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J Histochem Cytochem (1957) 10.83
Nucleosidediphosphatase activity in the Golgi apparatus and its usefulness for cytological studies. Proc Natl Acad Sci U S A (1961) 8.40
Duodenal and jejunal biopsies. II. Histology. Gastroenterology (1957) 4.61
The histochemical demonstration of leucine aminopeptidase. J Histochem Cytochem (1957) 3.64
Factors affecting the activity of adenosine triphosphatase and other phosphatases as measured by histochemical techniques. J Histochem Cytochem (1955) 2.89
Cytochemical localization of pyridine nucleotide-linked dehydrogenases. Nature (1958) 2.21
Indigogenic staining methods for esterases. Gen Cytochem Methods (1958) 1.90
Appearances of the jejunal mucosa in acute tropical sprue in Singapore. Gut (1966) 1.79
Jejunal biopsy in patients with malabsorptive disease. Scott Med J (1966) 1.34
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Mesoscale iron enrichment experiments 1993-2005: synthesis and future directions. Science (2007) 4.92
Small-bowel changes in dermatitis herpetiformis. Lancet (1966) 4.49
A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36
Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1992) 3.02
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Coeliac syndrome in dermatitis herpetiformis. Lancet (1968) 2.73
The rate of sebum excretion in man. Br J Dermatol (1969) 2.68
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Ending the routine guinea-pig test. Tubercle (1972) 2.56
Activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet (1979) 2.54
Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol (2001) 2.53
Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys (1995) 2.28
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine. J Physiol (1967) 2.13
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis (2005) 2.11
Pathogenesis of acne. Lancet (1969) 2.10
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Transition from maternal to embryonic control in early mammalian development: a comparison of several species. Mol Reprod Dev (1990) 2.07
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res (2000) 2.05
Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci (1995) 2.01
A system for the examination of tubercle bacilli and other mycobacteria. Tubercle (1976) 2.00
Purpura associated with vomiting in pregnancy. Br Med J (1973) 1.98
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res (2001) 1.95
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis. Br Med J (1980) 1.87
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet (1979) 1.87
Histamine weal formation and absorption in man. Br J Pharmacol (1980) 1.84
The S. pombe cdc16 gene is required both for maintenance of p34cdc2 kinase activity and regulation of septum formation: a link between mitosis and cytokinesis? EMBO J (1993) 1.80
The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol (1975) 1.79
Cell kinetics in flat (avillous) mucosa of the human small intestine. Gut (1973) 1.76
Opium, the religion of the people. Lancet (1985) 1.74
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci U S A (1997) 1.73
The prevalence of acne vulgaris in adolescence. Br J Dermatol (1971) 1.72
Psoriasis and cancer. Br Med J (1979) 1.71
Mechanism of action of antipruritic drugs. Br Med J (Clin Res Ed) (1983) 1.68
Control and function of sebaceous glands. Physiol Rev (1989) 1.65
Primary biliary cirrhosis--a revised clinical spectrum. Lancet (1981) 1.64
Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis (1971) 1.62
Siderophore presence in sputa of cystic fibrosis patients. Infect Immun (1991) 1.61
Melanoma epidemic: a midsummer night's dream? Br J Dermatol (2009) 1.61
Classification of Mycobacterium avium and related opportunist mycobacteria met in England and Wales. J Hyg (Lond) (1967) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
The control and measurement of sebum secretion. J Invest Dermatol (1974) 1.55
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev (2006) 1.51
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Mycobacterium szulgai--a new pathogen. Tubercle (1972) 1.49
Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. Am J Kidney Dis (1993) 1.48
Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol (1983) 1.47
Liver damage after paracetamol overdose. Comparison of liver-function tests, fasting serum bile acids, and liver histology. Lancet (1975) 1.46
Small-intestinal mucosal abnormalities in various skin diseases--fact or fancy? Gut (1970) 1.46
Occupation and Kansasii infection in Cardiff residents. Tubercle (1975) 1.45
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Thin-layer chromatography of mycobacterial lipids as an aid to classification: technical improvements: mycobacterium avium, M. intracellulare (Battey bacilli). Tubercle (1971) 1.43
Meeting the challenges facing research ethics committees: some practical suggestions. BMJ (1998) 1.43
Neglected vaginal ring pessary. J Obstet Gynaecol (2006) 1.42
A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma (2004) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Lack of effect of topical indomethacin on psoriasis. Br J Clin Pharmacol (1987) 1.42
Dw/LD-related molecular polymorphism of DR4 beta-chains. J Exp Med (1983) 1.42
Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol (1998) 1.41
Pancreatic trauma in Scottish children. J R Coll Surg Edinb (2000) 1.40
Has in-vitro fertilization made salpingostomy obsolete? Br J Obstet Gynaecol (1990) 1.40
Apoptosis and gastrointestinal disease. J Pediatr Gastroenterol Nutr (2000) 1.39
Effect of exercise on milk immunoglobulin A. Med Sci Sports Exerc (1997) 1.39
H1-receptor-active histamine not sole cause of chronic idiopathic urticaria. Lancet (1984) 1.38
Intraabdominal mesh prosthesis in a canine model. Surg Endosc (1994) 1.38
The cell cycle time in the flat (avillous) mucosa of the human small intestine. Gut (1973) 1.37
Assessment of the acoustic properties of common tissue-mimicking test phantoms. Ultrasound Med Biol (2003) 1.37
Patterns of hyaluronan staining are modified by fixation techniques. J Histochem Cytochem (1997) 1.36
Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal. Hernia (2007) 1.36
Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents. J Clin Microbiol (1985) 1.35
Harm minimisation for drug misusers. BMJ (1992) 1.35
Thin-layer chromatography of mycobacterial lipids as an aid to classification; Mycobacterium kansasii; and Mycobacterium marinum (balnei). Tubercle (1966) 1.35
HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. Lancet (1973) 1.34
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology (1987) 1.32
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Improvement of drg-sensitivity tests on tubercle bacilli. Tubercle (1970) 1.31
Molecular cloning and expression of a cDNA encoding the rabbit ileal villus cell basolateral membrane Na+/H+ exchanger. EMBO J (1991) 1.31
Organ-specific antibodies in patients with lichen sclerosus. Br Med J (1974) 1.30
The activity of S.pombe DSC-1-like factor is cell cycle regulated and dependent on the activity of p34cdc2. EMBO J (1993) 1.29
Biological purpose of acne. Lancet (1976) 1.29
Mycobacterium szulgai-a new pathogen. Serologic identification and report of five new cases. Am Rev Respir Dis (1973) 1.29
Incidence of small-intestinal mucosal abnormalities and of clinical coeliac disease in the relatives of children with coeliac disease. Gut (1971) 1.28
Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch B Cell Pathol (1978) 1.26
Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant (2006) 1.25
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25